NO139734C - Analogifremgangsmaate for fremstilling av fysiologisk aktive koblingsprodukter mellom et asparaginsyrederivat og et biologisk aktivt amin - Google Patents

Analogifremgangsmaate for fremstilling av fysiologisk aktive koblingsprodukter mellom et asparaginsyrederivat og et biologisk aktivt amin

Info

Publication number
NO139734C
NO139734C NO762199A NO762199A NO139734C NO 139734 C NO139734 C NO 139734C NO 762199 A NO762199 A NO 762199A NO 762199 A NO762199 A NO 762199A NO 139734 C NO139734 C NO 139734C
Authority
NO
Norway
Prior art keywords
preparation
acid derivative
asparaginic acid
biologically active
connection products
Prior art date
Application number
NO762199A
Other languages
English (en)
Other versions
NO139734B (no
NO762199L (no
Inventor
Jan B Boeler
Karl-Ludvig Reichelt
Original Assignee
Sentralinst For Ind Forskning
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sentralinst For Ind Forskning filed Critical Sentralinst For Ind Forskning
Priority to NO762199A priority Critical patent/NO139734C/no
Priority to GB26531/77A priority patent/GB1581271A/en
Priority to DE19772728644 priority patent/DE2728644A1/de
Priority to JP7535477A priority patent/JPS5318512A/ja
Priority to FR7719534A priority patent/FR2355802A1/fr
Priority to US05/810,471 priority patent/US4175084A/en
Publication of NO762199L publication Critical patent/NO762199L/no
Publication of NO139734B publication Critical patent/NO139734B/no
Publication of NO139734C publication Critical patent/NO139734C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/36Oxygen or sulfur atoms
    • C07D207/402,5-Pyrrolidine-diones
    • C07D207/4042,5-Pyrrolidine-diones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms, e.g. succinimide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/36Oxygen or sulfur atoms
    • C07D207/402,5-Pyrrolidine-diones
    • C07D207/4162,5-Pyrrolidine-diones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182Radicals derived from carboxylic acids
    • C07D295/185Radicals derived from carboxylic acids from aliphatic carboxylic acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Indole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrrole Compounds (AREA)
NO762199A 1976-06-25 1976-06-25 Analogifremgangsmaate for fremstilling av fysiologisk aktive koblingsprodukter mellom et asparaginsyrederivat og et biologisk aktivt amin NO139734C (no)

Priority Applications (6)

Application Number Priority Date Filing Date Title
NO762199A NO139734C (no) 1976-06-25 1976-06-25 Analogifremgangsmaate for fremstilling av fysiologisk aktive koblingsprodukter mellom et asparaginsyrederivat og et biologisk aktivt amin
GB26531/77A GB1581271A (en) 1976-06-25 1977-06-24 Coupling products of biologically active amines
DE19772728644 DE2728644A1 (de) 1976-06-25 1977-06-24 Physiologisch aktive verbindungen als kopplungsprodukte biologisch aktiver amine und verfahren zu ihrer herstellung
JP7535477A JPS5318512A (en) 1976-06-25 1977-06-24 Physiologically active compound
FR7719534A FR2355802A1 (fr) 1976-06-25 1977-06-24 Produits de couplage d'amines biologiquement actives
US05/810,471 US4175084A (en) 1976-06-25 1977-06-27 Coupling products of biologically active amines

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NO762199A NO139734C (no) 1976-06-25 1976-06-25 Analogifremgangsmaate for fremstilling av fysiologisk aktive koblingsprodukter mellom et asparaginsyrederivat og et biologisk aktivt amin

Publications (3)

Publication Number Publication Date
NO762199L NO762199L (no) 1977-12-28
NO139734B NO139734B (no) 1979-01-22
NO139734C true NO139734C (no) 1979-05-02

Family

ID=19882976

Family Applications (1)

Application Number Title Priority Date Filing Date
NO762199A NO139734C (no) 1976-06-25 1976-06-25 Analogifremgangsmaate for fremstilling av fysiologisk aktive koblingsprodukter mellom et asparaginsyrederivat og et biologisk aktivt amin

Country Status (6)

Country Link
US (1) US4175084A (no)
JP (1) JPS5318512A (no)
DE (1) DE2728644A1 (no)
FR (1) FR2355802A1 (no)
GB (1) GB1581271A (no)
NO (1) NO139734C (no)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0031297A3 (de) * 1979-12-07 1981-07-15 Ciba-Geigy Ag Pyrrolidin-2,5-dion-Derivate, Verfahren zu ihrer Herstellung und Verwendung als mikrobiozide Mittel

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3903077A (en) * 1973-04-05 1975-09-02 Abbott Lab Direct synthesis of dopamine amino acid amides

Also Published As

Publication number Publication date
NO139734B (no) 1979-01-22
JPS5318512A (en) 1978-02-20
FR2355802A1 (fr) 1978-01-20
NO762199L (no) 1977-12-28
GB1581271A (en) 1980-12-10
DE2728644A1 (de) 1978-01-05
FR2355802B1 (no) 1980-05-09
US4175084A (en) 1979-11-20

Similar Documents

Publication Publication Date Title
NO784211L (no) Analogifremgangsmaate for fremstilling av fysiologisk aktive acylanilid-derivater
NO784231L (no) Analogifremgangsmaate for fremstilling av fysiologisk aktive benzotiazinderivater
DK151009C (da) Analogifremgangsmaade til fremstilling af benzhydrylsulfinylforbindelser og fysiologisk acceptable syreadditionssalte deraf
IL50019A (en) N-(a-phenyl-benzylidene)aminoalkanoic acid derivatives their preparation and pharmaceutical compositions containing them
NO780151L (no) Fremgangsmaate for fremstilling av fysiologisk aktive acylderivater av aminosyrer
NO784397L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive ftalazin-4-yl-eddiksyrederivater
IT1085354B (it) Derivato dell'acido prostanico e procedimento per la sua preparazione
JPS5212144A (en) Production of phenylacetic acid derivatives and pharmaceutical agent having blood sugagar and lipid lowerling activities
NO773038L (no) Analogifremgangsmaate for fremstilling av fysiologisk aktive fenyletylaminer
NO152397C (no) Herbicid preparat inneholdende n-(fosfonometyl)-glycin og alfa-naftyleddiksyre
NO773327L (no) Analogifremgangsmaate for fremstilling av fysiologisk aktive pyrazolopyridiner
DK164699C (da) Analogifremgangsmaade til fremstilling af terapeutisk aktive aminopropanolderivater og fysiologisk acceptable syreadditionssalte heraf
DK307577A (da) 5-aroyl-1,2-dihydro-3h-pyrrol (1,2-a) pyrrol-1-carboxylsyrederivater og fremgangsmade til fremstilling deraf
NO780214L (no) Analogifremgangsmaate for fremstilling av fysiologisk aktive aminoalkoksyfenylderivater
NO163692C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive oksazafosforin-4-tio-alkansulfonsyrer og salter derav.
NO874850D0 (no) Fremgangsmaate for fremstilling av benzotiadiazinforbindelser og farmasoeytisk akseptable salter derav.
NO172051C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive karboksylsyreesterderivater og deglukoteicoplanin
NO139734C (no) Analogifremgangsmaate for fremstilling av fysiologisk aktive koblingsprodukter mellom et asparaginsyrederivat og et biologisk aktivt amin
NO772530L (no) Analogifremgangsm}te for fremstilling av n-(1`-allyl-2`-pyrrolidylmetyl)-2,3-dimetoksy-5-sulfamoylbenzamider og derivater derav
NO141014C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive 9-alkylamino-erytromyciner og deres salter
NZ184408A (en) 16-s-acyl derivatives of 16-deacetoxy-fusidic acid and pharmaceutical compositions
DK526976A (da) Picolinsyrerivater og fremgangsmade til fremstilling heraf
NO791237L (no) Analogifremgangsmaate for fremstilling av fysiologisk aktive pyridinderivater
DK0492667T3 (da) 1,4-Benzothiazin-2-eddikesyrederivater, fremgangsmåder til fremstilling deraf og anvendelse deraf
NO780191L (no) N2-arylsulfonyl-l-arginamider og farmasoeytisk fordragelige salter derav